ALPS Medical Breakthroughs ETF (NYSEARCA:SBIO) Short Interest Update

ALPS Medical Breakthroughs ETF (NYSEARCA:SBIO) was the recipient of a large drop in short interest during the month of January. As of January 30th, there was short interest totaling 19,893 shares, a drop of 55.0% from the January 15th total of 44,222 shares. Currently, 0.7% of the shares of the stock are sold short. Based on an average trading volume of 39,050 shares, the days-to-cover ratio is currently 0.5 days. Based on an average trading volume of 39,050 shares, the days-to-cover ratio is currently 0.5 days. Currently, 0.7% of the shares of the stock are sold short.

ALPS Medical Breakthroughs ETF Stock Down 0.6%

Shares of SBIO stock traded down $0.32 during trading on Thursday, hitting $50.29. The company had a trading volume of 41,688 shares, compared to its average volume of 51,117. The stock’s 50-day moving average is $51.32 and its two-hundred day moving average is $43.83. ALPS Medical Breakthroughs ETF has a 52 week low of $22.33 and a 52 week high of $54.79.

Hedge Funds Weigh In On ALPS Medical Breakthroughs ETF

Institutional investors have recently made changes to their positions in the stock. Delta Investment Management LLC bought a new stake in shares of ALPS Medical Breakthroughs ETF during the 4th quarter worth $6,112,000. LPL Financial LLC increased its stake in ALPS Medical Breakthroughs ETF by 438.7% in the fourth quarter. LPL Financial LLC now owns 42,755 shares of the company’s stock valued at $2,190,000 after acquiring an additional 34,819 shares during the last quarter. Strategic Financial Services Inc. raised its position in ALPS Medical Breakthroughs ETF by 97.8% during the second quarter. Strategic Financial Services Inc. now owns 38,032 shares of the company’s stock valued at $1,144,000 after purchasing an additional 18,807 shares in the last quarter. Griffin Asset Management Inc. raised its position in ALPS Medical Breakthroughs ETF by 1.9% during the fourth quarter. Griffin Asset Management Inc. now owns 30,699 shares of the company’s stock valued at $1,572,000 after purchasing an additional 564 shares in the last quarter. Finally, Jones Financial Companies Lllp bought a new stake in ALPS Medical Breakthroughs ETF during the first quarter worth about $782,000.

ALPS Medical Breakthroughs ETF Company Profile

The ALPS Medical Breakthroughs ETF (SBIO) is an exchange-traded fund that is based on the S-Network Medical Breakthroughs index. The fund tracks, a market-cap weighted index comprising US-listed biotech companies with one or more drugs currently in either Phase II or Phase III FDA clinical trials. SBIO was launched on Dec 31, 2014 and is managed by ALPS.